Mifepristone medical abortion in Albania: Results from a pilot clinical research study
Bracken,Hillary J.; Gliozheni,Orion; Kati,Kreston; Manoku,Nikita; Moisiu,Rubena; Shannon,Caitlin S.; Tare,Vjollca; Tasha,Ilir; Winikoff,Beverly
European Journal of Contraception and Reproductive Health Care 11(1): 38-46
Publication date: 2006
To explore the acceptability and feasibility of introducing mifepristone-misoprostol for early medical abortion in home and clinic settings in Albania.
This was a prospective study testing a simplified mifepristone-misoprostol regimen in two tertiary-level government health facilities in Tirana, Albania. Women (n = 409) with amenorrhea of 8 weeks or less received 200 mg mifepristone in the clinic and then chose whether to take 400 µg of oral misoprostol 2 days later either at home or in the clinic.
Nearly 97% of women successfully terminated their pregnancies using the simplified regimen. Almost all women found the method either satisfactory (49.4%) or highly satisfactory (41.1%). Almost all women who were given the option selected the home use protocol. Women choosing home administration of misoprostol were able to manage the medical abortion process on their own.
A reduced dose mifepristone medical abortion regimen with home administration of misoprostol is feasible for introduction into healthcare facilities in Albania.